Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis

AIMS: This study aimed at describing adalimumab pharmacokinetics (PK) and the concentration–effect relationship of adalimumab using pharmacokinetic–pharmacodynamic (PK–PD) modelling in patients with rheumatoid arthritis (RA). METHODS: Adalimumab PK and PK–PD data were obtained from a multicentric ob...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Clin Pharmacol
Egile Nagusiak: Ternant, David, Ducourau, Emilie, Fuzibet, Piéra, Vignault, Céline, Watier, Hervé, Lequerré, Thierry, Le Loët, Xavier, Vittecoq, Olivier, Goupille, Philippe, Mulleman, Denis, Paintaud, Gilles
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BlackWell Publishing Ltd 2015
Gaiak:
Pharmacokinetic Dynamic Relationships
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4309634/
https://ncbi.nlm.nih.gov/pubmed/25223394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12509
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak